These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 36429063)

  • 1. Mitochondrial Contribution to Inflammation in Diabetic Kidney Disease.
    Mitrofanova A; Fontanella AM; Burke GW; Merscher S; Fornoni A
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction in diabetic kidney disease.
    Forbes JM; Thorburn DR
    Nat Rev Nephrol; 2018 May; 14(5):291-312. PubMed ID: 29456246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose- and Non-Glucose-Induced Mitochondrial Dysfunction in Diabetic Kidney Disease.
    Ito M; Gurumani MZ; Merscher S; Fornoni A
    Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broadening horizons: the contribution of mitochondria-associated endoplasmic reticulum membrane (MAM) dysfunction in diabetic kidney disease.
    Liu Y; Qiao Y; Pan S; Chen J; Mao Z; Ren K; Yang Y; Feng Q; Liu D; Liu Z
    Int J Biol Sci; 2023; 19(14):4427-4441. PubMed ID: 37781026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria in Diabetic Kidney Disease.
    Ahmad AA; Draves SO; Rosca M
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of endoplasmic reticulum-mitochondria-associated membranes in diabetic kidney disease.
    Elwakiel A; Mathew A; Isermann B
    Cardiovasc Res; 2024 Feb; 119(18):2875-2883. PubMed ID: 38367274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease.
    Shahzad K; Fatima S; Khawaja H; Elwakiel A; Gadi I; Ambreen S; Zimmermann S; Mertens PR; Biemann R; Isermann B
    Kidney Int; 2022 Oct; 102(4):766-779. PubMed ID: 35779608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of progression of diabetic kidney disease mediated by podocyte mitochondrial injury.
    Su J; Ye D; Gao C; Huang Q; Gui D
    Mol Biol Rep; 2020 Oct; 47(10):8023-8035. PubMed ID: 32918716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective.
    Zheng W; Guo J; Liu ZS
    Clin Epigenetics; 2021 Apr; 13(1):87. PubMed ID: 33883002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of Inflammation and Oxidative Stress in the Development and Progression of Renal Disease in Diabetic Patients.
    Hojs R; Ekart R; Bevc S; Hojs N
    Nephron; 2016; 133(3):159-62. PubMed ID: 27344598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Mitochondria-Targeted Metabolic Tubular Injury in Diabetic Kidney Disease.
    Jiang H; Shao X; Jia S; Qu L; Weng C; Shen X; Wang Y; Huang H; Wang Y; Wang C; Feng S; Wang M; Feng H; Geekiyanage S; Davidson AJ; Chen J
    Cell Physiol Biochem; 2019; 52(2):156-171. PubMed ID: 30816665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk Between Lipids and Mitochondria in Diabetic Kidney Disease.
    Ducasa GM; Mitrofanova A; Fornoni A
    Curr Diab Rep; 2019 Nov; 19(12):144. PubMed ID: 31754839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the role of immunity and inflammation in diabetic kidney disease in the omics era.
    Hu X; Chen S; Ye S; Chen W; Zhou Y
    Front Immunol; 2024; 15():1342837. PubMed ID: 38487541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dysfunction in diabetic kidney disease.
    Wei PZ; Szeto CC
    Clin Chim Acta; 2019 Sep; 496():108-116. PubMed ID: 31276635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dynamics and diabetic kidney disease: Missing pieces for the puzzle of therapeutic approaches.
    Narongkiatikhun P; Chattipakorn SC; Chattipakorn N
    J Cell Mol Med; 2022 Jan; 26(2):249-273. PubMed ID: 34889040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Targeting of Mitochondria in Diabetic Kidney Disease.
    Cleveland KH; Schnellmann RG
    Pharmacol Rev; 2023 Mar; 75(2):250-262. PubMed ID: 36781216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of diabetic kidney disease and autophagy: A review.
    Yu J; Liu Y; Li H; Zhang P
    Medicine (Baltimore); 2023 Jul; 102(30):e33965. PubMed ID: 37505163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.
    Pichler R; Afkarian M; Dieter BP; Tuttle KR
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F716-F731. PubMed ID: 27558558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility.
    Qi H; Casalena G; Shi S; Yu L; Ebefors K; Sun Y; Zhang W; D'Agati V; Schlondorff D; Haraldsson B; Böttinger E; Daehn I
    Diabetes; 2017 Mar; 66(3):763-778. PubMed ID: 27899487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction in diabetic tubulopathy.
    Yao L; Liang X; Qiao Y; Chen B; Wang P; Liu Z
    Metabolism; 2022 Jun; 131():155195. PubMed ID: 35358497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.